An evaluation of the role of M30 Apoptosense (CK18 fragment) levels as a molecular marker and biomarker in cardiovascular damage
Cardiovascular Journal of Africa · 13.11.2026 · 37 (4) · 515-519
DOI: 10.5830/cvja-2026-058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Journal of Africa, online erschienen am 13.11.2026. Verfasst von Ömer Göç und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Although cardiopulmonary bypass (CPB) is a fundamental technique enabling the safe performance of cardiac surgery, it can trigger various mechanisms such as systemic inflammation, oxidative stress, ischaemia-reperfusion injury, and the cellular stress response. These processes may lead to an increase in apoptotic cellular damage during the postoperative period. M30 Apoptosense is a molecular biomarker that reflects a fragment of cytokeratin-18 cleaved by caspases and is used to assess apoptotic cell death.
Zitieren
APA
Göç, Ö., & Bağiş, M. (2026). An evaluation of the role of M30 Apoptosense (CK18 fragment) levels as a molecular marker and biomarker in cardiovascular damage. Cardiovascular Journal of Africa, 37(4), 515-519. https://doi.org/10.5830/cvja-2026-058
Vancouver
Göç Ö, Bağiş M. An evaluation of the role of M30 Apoptosense (CK18 fragment) levels as a molecular marker and biomarker in cardiovascular damage. Cardiovascular Journal of Africa. 2026;37(4):515-519. doi:10.5830/cvja-2026-058
BibTeX
@article{G2026,
author = {Göç, Ömer and Bağiş, Murat},
title = {An evaluation of the role of M30 Apoptosense (CK18 fragment) levels as a molecular marker and biomarker in cardiovascular damage},
journal = {Cardiovascular Journal of Africa},
year = {2026},
volume = {37},
number = {4},
pages = {515--519},
doi = {10.5830/cvja-2026-058}
}
EUVIMED